Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04886817 · ClinicalTrials.gov registry record · NA

Intervention to Reduce Sugar-Sweetened Beverage (SSB) Consumption in Children and Families

A NA study of Obesity, Childhood, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT04886817 is a NA study of Obesity, Childhood that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04886817, a NA study of Obesity, Childhood, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Pilot randomized trial of a technology-based intervention to reduce sugary drink consumption and promote water intake in families with young children.

Conditions Studied

Interventions

  • BEHAVIORAL Pilot Intervention to reduce SSB consumption in children and families

Study Locations (1)

North Carolina

  • Wake Forest School of Medicine - Winston-Salem

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-06-17
Est. Completion 2021-11-18
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04886817

The ClinicalTrials.gov registry entry for NCT04886817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (65% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 1 intervention - of which Pilot Intervention to reduce SSB consumption in children and families is the first listed.

NCT04886817 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04886817 about?

NCT04886817 is a clinical study titled "Intervention to Reduce Sugar-Sweetened Beverage (SSB) Consumption in Children and Families". Pilot randomized trial of a technology-based intervention to reduce sugary drink consumption and promote water intake in families with young children.

What is the current status of trial NCT04886817?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2021-06-17. Estimated completion is 2021-11-18.

What conditions does trial NCT04886817 study?

This clinical trial studies the following conditions: Obesity, Childhood.

What interventions are being tested in trial NCT04886817?

The interventions under investigation include: Pilot Intervention to reduce SSB consumption in children and families (BEHAVIORAL).

Who is sponsoring clinical trial NCT04886817?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04886817 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity, Childhood

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.